Abstract
SummaryThis second of two articles on the ‘typical’ (‘first-generation’) antipsychotics covers non-phenothiazines: thioxanthenes (flupentixol and zuclopenthixol), butyrophenones/diphenylbutylpiperidines (including one-time world market-leader haloperidol, and pimozide) and sulpiride, for many years the only substituted benzamide available in the UK. Several tolerability issues ascribed specifically or more frequently to older antipsychotics are also discussed.
Publisher
Cambridge University Press (CUP)
Subject
Psychiatry and Mental health
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016;British Journal of Clinical Pharmacology;2019-05-11
2. The development of antipsychotic drugs;Brain and Neuroscience Advances;2018-01
3. Trifluoperazine: A Sprightly Old Drug;Journal of Psychosocial Nursing and Mental Health Services;2016-01
4. Zuclopenthixol versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2015-12-01
5. Zuclopenthixol versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2013-06-18